Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers

Diagnostic Microbiology and Infectious Disease

Volumn 60, Issue 4, 2008, Pages 433-436

  Mendes, Rodrigo E ^a   Sader, Helio S ^a,b   Deshpande, Lalitagauri ^a   Jones, Ronald N ^a,c  

^a JMI LABORATORIES   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CA MRSA; Community acquired methicillin resistant S. aureus; cSSTI; Tigecycline

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; GENE; HEALTH CENTER; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NORTH AMERICA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

ACADEMIC MEDICAL CENTERS; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; COMMUNITY-ACQUIRED INFECTIONS; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EXOTOXINS; GENOTYPE; HUMANS; LEUKOCIDINS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; NORTH AMERICA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 40749085193     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.10.016     Document Type: Article

References (17)

1. CDC, Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections in correctional facilities-Georgia, California, and Texas, 2001-2003. MMWR Morb. Mortal. Wkly. Rep. 52 (2003) 992-996
2. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg. Infect. Dis. 7 (2001) 178-182
3. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, M7-A7. 7th ed. (2006), CLSI, Wayne, PA
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 17th Informational Supplement, M100-S17 (2007), CLSI, Wayne, PA
5. Davis S.L., Perri M.B., Donabedian S.M., Manierski C., Singh A., Vager D., Haque N.Z., Speirs K., Muder R.R., Robinson-Dunn B., Hayden M.K., and Zervos M.J. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J. Clin. Microbiol. 45 (2007) 1705-1711
6. Ellis-Grosse E.J., Babinchak T., Dartois N., Rose G., and Loh E. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam. Clin. Infect. Dis. 41 Suppl 5 (2005) S341-S353
7. Gould I.M. Community-acquired MRSA, can we control it?. Lancet 368 (2006) 824-826
8. Herold B.C., Immergluck L.C., Maranan M.C., Lauderdale D.S., Gaskin R.E., Boyle-Vavra S., Leitch C.D., and Daum R.S. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 279 (1998) 593-598
9. Jones C.H., Tuckman M., Howe A.Y., Orlowski M., Mullen S., Chan K., and Bradford P.A. Diagnostic PCR analysis of the occurrence of methicillin and tetracycline resistance genes among Staphylococcus aureus isolates from phase 3 clinical trials of tigecycline for complicated skin and skin structure infections. Antimicrob. Agents Chemother. 50 (2006) 505-510
10. Jones R.N., Nilius A.M., Akinlade B.K., Deshpande L.M., and Notario G.F. Molecular characterization of Staphylococcus aureus isolates from a 2005 clinical trial of uncomplicated skin and skin structure infections. Antimicrob. Agents Chemother. 51 (2007) 3381-3384
11. Kazakova S.V., Hageman J.C., Matava M., Srinivasan A., Phelan L., Garfinkel B., Boo T., McAllister S., Anderson J., Jensen B., Dodson D., Lonsway D., McDougal L.K., Arduino M., Fraser V.J., Killgore G., Tenover F.C., Cody S., and Jernigan D.B. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352 (2005) 468-475
12. King M.D., Humphrey B.J., Wang Y.F., Kourbatova E.V., Ray S.M., and Blumberg H.M. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144 (2006) 309-317
13. Lina G., Piemont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., Vandenesch F., and Etienne J. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29 (1999) 1128-1132
14. Miller L.G., Perdreau-Remington F., Bayer A.S., Diep B., Tan N., Bharadwa K., Tsui J., Perlroth J., Shay A., Tagudar G., Ibebuogu U., and Spellberg B. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin. Infect. Dis. 44 (2007) 471-482
15. Oliveira D.C., and de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46 (2002) 2155-2161
16. Takizawa Y., Taneike I., Nakagawa S., Oishi T., Nitahara Y., Iwakura N., Ozaki K., Takano M., Nakayama T., and Yamamoto T. A Panton-Valentine leucocidin (PVL)-positive community-acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan. J Clin Microbiol 43 (2005) 3356-3363
17. Tenover F.C., McDougal L.K., Goering R.V., Killgore G., Projan S.J., Patel J.B., and Dunman P.M. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J. Clin. Microbiol. 44 (2006) 108-118